Over 1.8 million nonprofits and charities for donors, volunteers and funders

2016 Top-Rated Nonprofit

Multidisciplinary Association For Psychedelic Studies

Claim This Nonprofit

More Info

Add to Favorites

Share this Nonprofit

Donate

Volunteering Oportunities

Nonprofit Overview

Causes: Government & Public Administration, Health, Medical Research, Mental Health, Mental Health Treatment

Mission: Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served: Worldwide

Programs: Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

Community Stories

285 Stories from Volunteers, Donors & Supporters

General Member of the Public

Rating: 5

I first learned about psychedelics during undergrad working towards my BS in Neuroscience & have been amazed by their huge potential for helping mental illness both in my academic research and personal experiences.

MAPS has had similar interests & research goals as myself & would love to be involved in any way with the organization!

I firmly believe countless peoples's lives could benefit from psychedelic drugs in a controlled, medical context. Personally, my experiences with MDMA, ayahuasca & psilocybe fungi have, on separate occasions, helped me immensely in my own battles with anxiety & depression. It is because of these & legitimate academic research that lead me to believe in the potential of psychedelic drugs.

General Member of the Public

Rating: 5

It is difficult as an individual to fight the unjust predispositions that society has towards psychedelics and marijuana usage for therapy. Being a member of MAPS I feel empowered knowing that as a group we have a larger voice and a stronger support system.

General Member of the Public

Rating: 5

Watson & Crick were using psychedelics when working on the structure of DNA. What other great scientific discoveries have been lost by criminalising psychedelics? Society needs organisations like this to end the War on psychedelics.

General Member of the Public

Rating: 5

MAPS uses a perfect combo of substance induction and therapy which leads to improvements in patients and them leaving substance free unlike our current Western model but unfortunately due to information censorship, there are a lot of promising discoveries out there that aren't getting enough attention.

What often goes unmentioned is the fact that materialist science cannot explain all the phenomena out there though seems to claim far more power.

Psychedelic substances explore the field of consciousness so well and can be done in safe and controlled ways. I feel MAPS sticks to this priority really well in their work!

Antonio4

General Member of the Public

Rating: 5

This organization is paving the way for the future of our civilization. I believe that the staff @ MAPPS
are heroes of our times just like our soldiers @ war. I appreciate every moning that all of those minds are collaborating to help the future of our species better understand our abilities in self exploration & self healing! May this organization receive all help, acknowledgements, & blessings from every corner of the universe!

Toren W.

General Member of the Public

Rating: 5

Psychedelic research is a deadly subject to touch in the scientific world. But MAPS does an excellent job at professionalizing and utilizing their purpose and goals. If psychedelics and marijuana had a face, MAPS deserves to represent them.

General Member of the Public

Rating: 5

MAPS is an association that is necessary for the world growth in studies of consciousness. While pharmaceutical industries lobby against the modernization of laws by the result of an enriched psychedelic community, people with problems are being helped, and MAPS is a part of that. As we enter a new age of awareness, MAPS must be at the forefront of protecting the sovereign rights of individual consciousness. Treating a multitude of symptoms, psychedelics has already had profound effects, and must no longer be trivialized with 60's propaganda an irresponsible use in our current societies.

General Member of the Public

Rating: 5

I've been studying the topic of Psychedelics for a couple years now, and MAPS has been a wonderful tool in bringing together great minds and equally great results.
Said results are, indeed, bringing life-changing results to those suffering from Depression, Post-traumatic Stress Disorder, and Drug Addictions.
This is the first organization, in years, that I've been actively talking about in my circle of friends and family.

General Member of the Public

Rating: 4

They carry out such useful studies on the uses of psychoactive substances to help those in need of healing.

Previous Stories
9

General Member of the Public

Rating: 5

MAPS provides a very special service by supporting legitimate research in etheogens and showing what an important role they can play in our lives.

Review from Guidestar

Craig14

General Member of the Public

Rating: 5

MAPS is attempting the impossible: changing the prevailing attitudes around psychedelics from "strictly for stoner rejects" to "full of potential for healing." And you know what? Somehow, it's working! By consistently getting solid research done and presenting the results to the world, people are waking up to the possibilities. Thank you, MAPS!

Isis T.

General Member of the Public

Rating: 5

MAPS are doing really amazing researches. It's so important to research psychedelics and find how to use them as treatment. Actually, I'd even like to join MAPS in future as a scientist.

Alan G.

General Member of the Public

Rating: 5

MAPS work has been essential for the development of a well informed and consistent argument against the "war on drugs"and the social significance that the end of such war would have is a major positive shift for human kind.

General Member of the Public

Rating: 5

The brave folks at MAPS work tirelessly to help change perceptions about the medical use of these extraordinary compounds. In our world today, increasingly dangerous and expensive pharmaceuticals dominate the treatment options available to many patients who could be helped safely and effectively using psychedelics. MAPS is doing the research that may well change that.

General Member of the Public

Rating: 5

MAPS is a fantastic organization, dedicated to human beings. While utilizing complementary therapies and strategies for overcoming unbearably traumatic experiences, they are consistent in their message, actions and heart. Here here to Maps! Long live the organization and all the people who have benefited from their painstaking battle to make legal those therapies and methodologies!

Previous Stories
4

General Member of the Public

Rating: 5

MAPS is absolutely leading the pack with its intensive efforts to alleviate (and in most cases eliminate) the suffering of millions through unconventional therapeutic means. The courage and determination of this non-profit are evident in their compassionate, reasonable and relentless pursuit for legal clinical trials. MAPS has opened doors and minds. These less conventional means deserve study and education of the masses who do not yet understand. I strongly believe in MAPS and the fantastic causes the people within it continue to make on a moment to moment basis.

Review from Guidestar

General Member of the Public

Rating: 5

In a field like psychadelics, the overall health effects aren't well known. Thanks to MAPS we're finding out more about these drugs and how they affect us and their research has the potential to help millions of people

6

General Member of the Public

Rating: 5

MAPS is the only organization providing the world with essential research on a subject other nonprofits are too timid to deal with. Psychedelic research is becoming more legitimate because of what MAPS has done.

8

General Member of the Public

Rating: 5

The MAPS material is always varied. It academic without being overwhelming, and they also tackle some of the more quirky experiences resulting from psychedelic use - one story which springs to mind, if I remember correctly, is of someone learning to wrrite with their left hand after taking MDMA, putting questions to it and getting instructive and unexpeced responses.

5

General Member of the Public

Rating: 5

MAPS is an extremely important organization, one that goes against the grain in a certain sense, in that it relies on "outside the box" thinking in order to solve some of the problems that face modern society. While many people may shun or look down upon the work that they do, I feel that it is absolutely essential that their research continues and expands, as they are on the brink of some of the most important and helpful scientific discoveries of our times, and have the capability to vastly improve the lives of millions of people around the world.

7

General Member of the Public

Rating: 5

Since the discovery of psychedelic drugs the human entity had a clear and concise avenue into understanding the conscious and unconscious mind, however, it’s a shame that the illicit user is selfish and naïve, for they ruined an alluring apparatus that was useful in psychotherapy. Considerable knowledge of philosophical and scientific terminology has allowed for many to be skeptical, thus, facilitating an inclination towards emancipation and intellectual understanding of the human brain and how it processes. Such research and practice leads one to the never-ending inquiry of what is happening inside the brain neurologically; resulting in limitless and perpetual questions. However, they are eligible and testable questions. With the recent permission and alluring indulgent of psychedelics, we incline towards a better today, tomorrow and relief from the disquieting past that intrudes and haunts our thoughts. P.S. If anyone would like to read a literature review that I gathered and researched please feel free to personally email me at Zcassista849@students.ccsnh.edu, or call me at (603)-305-8094. Or if you have one to share, I would be drastically be interested. Thank you, Zachary Cassista

6

General Member of the Public

Rating: 5

What the government, most of academia, and private companies fail to do, MAPS provides desperately needed, cutting edge research for the benefit of mental health. As mental health issues seem to burgeon with new and old disorders throughout the worlds' population, MAPS is needed now more than ever.